Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Vascular Targeting and Therapeutics for Squamous Cell Carcinoma of the Head and Neck

Vascular Targeting and Therapeutics for Squamous Cell Carcinoma of the Head and Neck Close to 38 500 new cases of squamous cell carcinoma of the head and neck (SCCHN) are diagnosed each year. Traditional therapy for SCCHN has involved a multimodality approach of radiotherapy, surgery, and chemotherapy. More recently, novel therapeutic targets for solid tumors, including SCCHN, have been subject to preclinical and clinical applications. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Cancer Springer Journals

Vascular Targeting and Therapeutics for Squamous Cell Carcinoma of the Head and Neck

American Journal of Cancer , Volume 5 (1) – Aug 10, 2012

Loading next page...
 
/lp/springer-journals/vascular-targeting-and-therapeutics-for-squamous-cell-carcinoma-of-the-6xw0i0WCXR
Publisher
Springer Journals
Copyright
Copyright © 2006 by Adis Data Information BV
Subject
Pharmacy; Pharmacy
ISSN
1175-6357
DOI
10.2165/00024669-200605010-00002
Publisher site
See Article on Publisher Site

Abstract

Close to 38 500 new cases of squamous cell carcinoma of the head and neck (SCCHN) are diagnosed each year. Traditional therapy for SCCHN has involved a multimodality approach of radiotherapy, surgery, and chemotherapy. More recently, novel therapeutic targets for solid tumors, including SCCHN, have been subject to preclinical and clinical applications.

Journal

American Journal of CancerSpringer Journals

Published: Aug 10, 2012

References